Bringing the fundamentals into focus…
Back to Dianthus Therapeutics, Inc.
How Dianthus Therapeutics, Inc. stacks up
DNTH · against 244 other Healthcare companies of similar size
Overall
29/ 100
Near the bottom of its peers.
Ranked #225 of 245 · scores higher than 8% of peers
Bars: peers in each 10-point band of the overall score15 peers with an overall score of 20–29, including DNTH · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around DNTH| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 3 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 4 | 19.7B HKD (≈$2.5B) | 84 | 84 | 98 | 87 | 0 / 2 | |
| 4 | 2.7B USD | 84 | 75 | 98 | 99 | 1 / 2 | |
| 220 | 6.0B USD | 30 | 8 | 82 | 28 | 2 / 2 | |
| 220 | 4.0B USD | 30 | 8 | — | 16 | 0 / 2 | |
| 220 | 5.7B USD | 30 | 8 | 90 | 13 | 2 / 2 | |
| 220 | 7.8B USD | 30 | 8 | 4 | 20 | 0 / 2 | |
| 225 | 4.6B USD | 29 | 8 | 5 | 5 | 0 / 2 | |
| 226 | 8.4B USD | 28 | 8 | 74 | 21 | 2 / 2 | |
| 226 | 8.5B USD | 28 | 8 | 37 | 26 | 1 / 2 | |
| 226 | 3.7B USD | 28 | 8 | 6 | 4 | 0 / 2 | |
| 229 | 4.8B USD | 27 | 8 | 5 | 5 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score